MicroRNA-301a regulation of a T-helper 17 immune response controls autoimmune demyelination

Proceedings of the National Academy of Sciences of the United States of America

Volumn 109, Issue 20, 2012, Pages

  Mycko, Marcin P ^a   Cichalewska, Maria ^a   Machlanska, Agnieszka ^a   Cwiklinska, Hanna ^a   Mariasiewicz, Magdalena ^a   Selmaj, Krzysztof W ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTAGOMIR; AUTOANTIGEN; GAMMA INTERFERON; INTERLEUKIN 23; INTERLEUKIN 4; INTERLEUKIN 6; MICRORNA; MICRORNA 155; MICRORNA 21; MICRORNA 301A; MYELIN; PIAS3 PROTEIN; PROTEIN INHIBITOR OF ACTIVATED STAT; STAT3 PROTEIN; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL MODEL; ANTIGEN RECOGNITION; ARTICLE; CD4+ T LYMPHOCYTE; CELL INFILTRATION; CELL MATURATION; CELLULAR IMMUNITY; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; CYTOKINE RELEASE; DEMYELINATION; DISEASE SEVERITY; DOWN REGULATION; GENE OVEREXPRESSION; IMMUNIZATION; IMMUNOSTIMULATION; IN VITRO STUDY; IN VIVO STUDY; LYMPH NODE CELL; LYMPHOCYTE DIFFERENTIATION; MACROPHAGE; MICROGLIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TH17 CELL; UPREGULATION;

ANIMALS; BLOTTING, WESTERN; CD4-POSITIVE T-LYMPHOCYTES; DNA PRIMERS; DNA-BINDING PROTEINS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; LUCIFERASES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICRORNAS; PROTEIN INHIBITORS OF ACTIVATED STAT; REAL-TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; STATISTICS, NONPARAMETRIC; TH17 CELLS;

ANIMALIA;

EID: 84861207616     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1114325109     Document Type: Article

References (54)

1. SospedraM, Martin R (2005) Immunology of multiple sclerosis. Annu Rev Immunol 23: 683-747. (Pubitemid 40563183)
2. Hafler DA (2004) Multiple sclerosis. J Clin Invest 113:788-794.
3. Bettelli E, Korn T, Oukka M, Kuchroo VK (2008) Induction and effector functions of T(H)17 cells. Nature 453:1051-1057. (Pubitemid 351871737)
4. Eugster HP, Frei K, Kopf M, Lassmann H, Fontana A (1998) IL-6-deficient mice resist myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. Eur J Immunol 28:2178-2187. (Pubitemid 28321302)
5. Bettelli E, et al. (2006) Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441:235-238.
6. Cua DJ, et al. (2003) Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 421:744-748. (Pubitemid 36227625)
7. Xiao C, Rajewsky K (2009) MicroRNA control in the immune system: Basic principles. Cell 136:26-36.
8. Jinek M, Doudna JA (2009) A three-dimensional view of the molecular machinery of RNA interference. Nature 457:405-412.
9. Selbach M, et al. (2008) Widespread changes in protein synthesis induced by microRNAs. Nature 455:58-63.
10. Du C, et al. (2009) MicroRNA miR-326 regulates TH-17 differentiation and is associated with the pathogenesis of multiple sclerosis. Nat Immunol 10:1252-1259.
11. O'Connell RM, et al. (2010) MicroRNA-155 promotes autoimmune inflammation by enhancing inflammatory T cell development. Immunity 33:607-619.
12. Ponomarev ED, Veremeyko T, Barteneva N, Krichevsky AM, Weiner HL (2011) MicroRNA-124 promotes microglia quiescence and suppresses EAE by deactivating macrophages via the C/EBP-alpha-PU.1 pathway. Nat Med 17(1):64-70.
13. Krützfeldt J, et al. (2005) Silencing of microRNAs in vivo with 'antagomirs'. Nature 438:685-689.
14. Krützfeldt J, et al. (2007) Specificity, duplex degradation and subcellular localization of antagomirs. Nucleic Acids Res 35:2885-2892. (Pubitemid 47073627)
15. Bettelli E, et al. (2003) Myelin oligodendrocyte glycoprotein-specific T cell receptor transgenic mice develop spontaneous autoimmune optic neuritis. J Exp Med 197: 1073-1081. (Pubitemid 36570063)
16. Rodriguez A, et al. (2007) Requirement of bic/microRNA-155 for normal immune function. Science 316:608-611. (Pubitemid 46683148)
17. Reboldi A, et al. (2009) C-C chemokine receptor 6-regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE. Nat Immunol 10:514-523.
18. Korn T, Bettelli E, Oukka M, Kuchroo VK (2009) IL-17 and Th17 Cells. Annu Rev Immunol 27:485-517.
19. Yang XO, et al. (2007) STAT3 regulates cytokine-mediated generation of inflammatory helper T cells. J Biol Chem 282:9358-9363. (Pubitemid 47104613)
20. Zhou L, et al. (2007) IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat Immunol 8:967-974. (Pubitemid 47300011)
21. Chen RH, Chang MC, Su YH, Tsai YT, Kuo ML (1999) Interleukin-6 inhibits transforming growth factor-beta-induced apoptosis through the phosphatidylinositol 3-kinase/Akt and signal transducers and activators of transcription 3 pathways. J Biol Chem 274:23013-23019.
22. Heinrich PC, Behrmann I, Müller-Newen G, Schaper F, Graeve L (1998) Interleukin-6- type cytokine signalling through the gp130/Jak/STAT pathway. Biochem J 334: 297-314. (Pubitemid 28448572)
23. Lu Z, et al. (2011) miR-301a as an NF-κB activator in pancreatic cancer cells. EMBO J 30: 57-67.
24. Shi W, et al. (2011) MicroRNA-301 mediates proliferation and invasion in human breast cancer. Cancer Res 71:2926-2937.
25. Cobb BS, et al. (2005) T cell lineage choice and differentiation in the absence of the RNase III enzyme Dicer. J Exp Med 201:1367-1373. (Pubitemid 40664081)
26. Lu LF, et al. (2010) Function of miR-146a in controlling Treg cell-mediated regulation of Th1 responses. Cell 142:914-929.
27. Cobb BS, et al. (2006) A role for Dicer in immune regulation. J Exp Med 203: 2519-2527. (Pubitemid 44664621)
28. Liston A, Lu LF, O'Carroll D, Tarakhovsky A, Rudensky AY (2008) Dicer-dependent microRNA pathway safeguards regulatory T cell function. J Exp Med 205:1993-2004.
29. Chong MM, Rasmussen JP, Rudensky AY, Littman DR (2008) The RNAseIII enzyme Drosha is critical in T cells for preventing lethal inflammatory disease. J Exp Med 205: 2005-2017.
30. Zhou X, et al. (2008) Selective miRNA disruption in T reg cells leads to uncontrolled autoimmunity. J Exp Med 205:1983-1991.
31. Zhou L, et al. (2009) Tie2cre-induced inactivation of the miRNA-processing enzyme Dicer disrupts invariant NKT cell development. Proc Natl Acad Sci USA 106: 10266-10271.
32. Fedeli M, et al. (2009) Dicer-dependent microRNA pathway controls invariant NKT cell development. J Immunol 183:2506-2512.
33. Muljo SA, et al. (2005) Aberrant T cell differentiation in the absence of Dicer. J Exp Med 202:261-269. (Pubitemid 41043822)
34. Griffiths-Jones S, Saini HK, van Dongen S, Enright AJ (2008) miRBase: Tools for microRNA genomics. Nucleic Acids Res 36(Database issue):D154-D158. (Pubitemid 351149713)
35. Zhang N, Bevan MJ (2010) Dicer controls CD8+ T-cell activation, migration, and survival. Proc Natl Acad Sci USA 107:21629-21634.
36. Kuchen S, et al. (2010) Regulation of microRNA expression and abundance during lymphopoiesis. Immunity 32:828-839.
37. Braconi C, Huang N, Patel T (2010) MicroRNA-dependent regulation of DNA methyltransferase-1 and tumor suppressor gene expression by interleukin-6 in human malignant cholangiocytes. Hepatology 51:881-890.
38. Yagil Z, et al. (2010) The enigma of the role of protein inhibitor of activated STAT3 (PIAS3) in the immune response. Trends Immunol 31:199-204.
39. Chung CD, et al. (1997) Specific inhibition of Stat3 signal transduction by PIAS3. Science 278:1803-1805. (Pubitemid 27527648)
40. Liu B, Tahk S, Yee KM, Fan G, Shuai K (2010) The ligase PIAS1 restricts natural regulatory T cell differentiation by epigenetic repression. Science 330:521-525.
41. Haasch D, et al. (2002) T cell activation induces a noncoding RNA transcript sensitive to inhibition by immunosuppressant drugs and encoded by the proto-oncogene, BIC. Cell Immunol 217:78-86. (Pubitemid 35352162)
42. Jindra PT, Bagley J, Godwin JG, Iacomini J (2010) Costimulation-dependent expression of microRNA-214 increases the ability of T cells to proliferate by targeting Pten. J Immunol 185:990-997.
43. Junker A, et al. (2009) MicroRNA profiling of multiple sclerosis lesions identifies modulators of the regulatory protein CD47. Brain 132:3342-3352.
44. Dorsett Y, et al. (2008) MicroRNA-155 suppresses activation-induced cytidine deaminase-mediated Myc-Igh translocation. Immunity 28:630-638.
45. Thai TH, et al. (2007) Regulation of the germinal center response by microRNA-155. Science 316:604-608.
46. Vigorito E, et al. (2007) microRNA-155 regulates the generation of immunoglobulin class-switched plasma cells. Immunity 27:847-859. (Pubitemid 350258623)
47. Tili E, et al. (2007) Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNF-alpha stimulation and their possible roles in regulating the response to endotoxin shock. J Immunol 179:5082-5089.
48. Androulidaki A, et al. (2009) The kinase Akt1 controls macrophage response to lipopolysaccharide by regulating microRNAs. Immunity 31:220-231.
49. O'Connell RM, Chaudhuri AA, Rao DS, Baltimore D (2009) Inositol phosphatase SHIP1 is a primary target of miR-155. Proc Natl Acad Sci USA 106:7113-7118.
50. Wu H, et al. (2007) miRNA profiling of naïve, effector and memory CD8 T cells. PLoS ONE 2:e1020.
51. Rouas R, et al. (2009) Human natural Treg microRNA signature: Role of microRNA-31 and microRNA-21 in FOXP3 expression. Eur J Immunol 39:1608-1618.
52. Pan W, et al. (2010) MicroRNA-21 and microRNA-148a contribute to DNA hypomethylation in lupus CD4+ T cells by directly and indirectly targeting DNA methyltransferase 1. J Immunol 184:6773-6781.
53. Volinia S, et al. (2006) A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 103:2257-2261. (Pubitemid 43271657)
54. Krichevsky AM, Gabriely G (2009) miR-21: A small multi-faceted RNA. J Cell Mol Med 13:39-53.